However, emerging evidence suggests that GLP-1RAs could be beneficial for specific eating disorder symptoms in individuals with obesity who do not have diabetes, potentially reducing binge eating, dietary disinhibition, overall eating disorder psychopathology, and concerns about body shape (Chao et al., 2019)
Studies have shown that GLP-1-based therapies can reduce both mast cell and macrophage infiltration in various organ systems, potentially explaining why patients often experience improvements across multiple symptoms simultaneously
If youre currently taking medications or supplements, its helpful to bring a list as well
Glucagon-like peptide-1 (GLP-1) is a peptide hormone comprising 30 or 31 amino acids, and is secreted by L cells in the distal gut, -cells in the pancreas, and the hypothalamus and nucleus of the solitary tract in the central nervous system (18)
If you enjoy it, you can continue with one of their tiered payment plans